Tumour progression was monitored three times a week using IVIS, revealing that both the WCCV with soluble β-glucan and ICC@G-PL-vaccinated mice exhibited attenuated tumour progression, as indicated by the reduced radiance. The gene discussed is PPIB; the disease is intrahepatic cholangiocarcinoma.